期刊
AGING AND DISEASE
卷 12, 期 4, 页码 1070-1080出版社
INT SOC AGING & DISEASE
DOI: 10.14336/AD.2021.0211
关键词
epilepsy; drug-resistant epilepsy; neuromodulation; neurostimulation; VNS; RNS; DBS
Epilepsy affects millions worldwide, with drug-resistant cases posing a challenge for surgical intervention. Neuromodulation therapies like VNS, RNS, and DBS may offer alternative treatment options for these patients.
Epilepsy affects approximately 70 million people worldwide, and it is a significant contributor to the global burden of neurological disorders. Despite the advent of new AEDs, drug resistant-epilepsy continues to affect 30-40% of PWE. Once identified as having drug-resistant epilepsy, these patients should be referred to a comprehensive epilepsy center for evaluation to establish if they are candidates for potential curative surgeries. Unfortunately, a large proportion of patients with drug-resistant epilepsy are poor surgical candidates due to a seizure focus located in eloquent cortex, multifocal epilepsy or inability to identify the zone of ictal onset. An alternative treatment modality for these patients is neuromodulation. Here we present the evidence, indications and safety considerations for the neuromodulation therapies in vagal nerve stimulation (VNS), responsive neurostimulation (RNS), or deep brain stimulation (DBS).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据